Gondi Kumar

5.6k total citations
53 papers, 2.5k citations indexed

About

Gondi Kumar is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Gondi Kumar has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Molecular Biology and 18 papers in Pharmacology. Recurrent topics in Gondi Kumar's work include Pharmacogenetics and Drug Metabolism (13 papers), Cancer Treatment and Pharmacology (13 papers) and HIV/AIDS drug development and treatment (10 papers). Gondi Kumar is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Cancer Treatment and Pharmacology (13 papers) and HIV/AIDS drug development and treatment (10 papers). Gondi Kumar collaborates with scholars based in United States, Switzerland and United Kingdom. Gondi Kumar's co-authors include Sekhar Surapaneni, Jon F. Denissen, Thomas Walle, U. Kristina Walle, A. David Rodrigues, Alex Buko, Kapil N. Bhalla, Henry Lau, Nianhang Chen and Dale J. Kempf and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Gondi Kumar

52 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gondi Kumar United States 24 894 826 788 654 523 53 2.5k
Bernard P. Murray United States 24 575 0.6× 491 0.6× 540 0.7× 761 1.2× 238 0.5× 61 2.0k
David R. Jones United States 19 765 0.9× 373 0.5× 576 0.7× 979 1.5× 210 0.4× 35 2.3k
Gareth J. Veal United Kingdom 32 1.0k 1.1× 391 0.5× 1.3k 1.7× 244 0.4× 243 0.5× 136 3.7k
M. J. X. Hillebrand Netherlands 31 812 0.9× 288 0.3× 769 1.0× 221 0.3× 127 0.2× 77 2.6k
Jeffrey A. Silverman United States 35 2.0k 2.2× 264 0.3× 1.1k 1.4× 619 0.9× 94 0.2× 93 3.8k
Kimberly K. Adkison United States 21 606 0.7× 404 0.5× 368 0.5× 435 0.7× 309 0.6× 42 1.7k
Julia Blievernicht Germany 10 510 0.6× 365 0.4× 230 0.3× 593 0.9× 212 0.4× 10 1.3k
Lindsey O. Webster United States 11 1.0k 1.2× 398 0.5× 398 0.5× 321 0.5× 132 0.3× 14 1.7k
Matthew Wright United States 25 352 0.4× 171 0.2× 472 0.6× 284 0.4× 104 0.2× 85 1.8k
Janelle M. Hoskins United States 23 1.0k 1.2× 174 0.2× 805 1.0× 479 0.7× 50 0.1× 72 2.3k

Countries citing papers authored by Gondi Kumar

Since Specialization
Citations

This map shows the geographic impact of Gondi Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gondi Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gondi Kumar more than expected).

Fields of papers citing papers by Gondi Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gondi Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gondi Kumar. The network helps show where Gondi Kumar may publish in the future.

Co-authorship network of co-authors of Gondi Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Gondi Kumar. A scholar is included among the top collaborators of Gondi Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gondi Kumar. Gondi Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Narayanan, Rangaraj, Matthew Hoffmann, Gondi Kumar, & Sekhar Surapaneni. (2016). Application of a “Fit for Purpose” PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide. Drug Metabolism Letters. 10(3). 172–179. 9 indexed citations
3.
Atsriku, Christian, Matthew Hoffmann, Ying Ye, Gondi Kumar, & Sekhar Surapaneni. (2014). Metabolism and disposition of a potent and selective JNK inhibitor [14C]tanzisertib following oral administration to rats, dogs and humans. Xenobiotica. 45(5). 428–441. 5 indexed citations
4.
Tong, Zeen, Usha Yerramilli, Sekhar Surapaneni, & Gondi Kumar. (2014). The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug–drug interactions. Cancer Chemotherapy and Pharmacology. 73(4). 869–874. 15 indexed citations
5.
Li, Yan, Simon Zhou, Matthew Hoffmann, Gondi Kumar, & Maria Palmisano. (2014). Modeling and Simulation to Probe the Pharmacokinetic Disposition of Pomalidomide R- and S-Enantiomers. Journal of Pharmacology and Experimental Therapeutics. 350(2). 265–272. 11 indexed citations
6.
Hoffmann, Matthew, Claudia Kasserra, Peter Schäfer, et al.. (2012). Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration. Cancer Chemotherapy and Pharmacology. 71(2). 489–501. 98 indexed citations
7.
Qian, Wenyuan, Jian Jeffrey Chen, Jiawang Zhu, et al.. (2011). Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency. Bioorganic & Medicinal Chemistry Letters. 22(2). 1061–1067. 7 indexed citations
8.
Chen, Nianhang, et al.. (2011). Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects. Cancer Chemotherapy and Pharmacology. 69(3). 789–797. 73 indexed citations
9.
Biswas, Kaustav, Wenyuan Qian, Jian Jeffrey Chen, et al.. (2008). Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 18(17). 4764–4769. 16 indexed citations
10.
Kumar, Gondi, Henry Lau, & Oscar L. Laskin. (2008). Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction. Cancer Chemotherapy and Pharmacology. 63(6). 1171–1175. 28 indexed citations
11.
Chen, Nianhang, et al.. (2007). Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis. The Journal of Clinical Pharmacology. 47(12). 1466–1475. 202 indexed citations
12.
Surapaneni, Sekhar, et al.. (2006). IDENTIFICATION OF A NOVEL IN VITRO METABONATE FROM LIVER MICROSOMAL INCUBATIONS. Drug Metabolism and Disposition. 34(6). 901–905. 10 indexed citations
13.
Kumar, Gondi & Sekhar Surapaneni. (2001). Role of drug metabolism in drug discovery and development. Medicinal Research Reviews. 21(5). 397–411. 157 indexed citations
14.
Kumar, Gondi, Ellen Roberts, Dean Hickman, et al.. (1999). Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction. Drug Metabolism and Disposition. 27(8). 902–908. 133 indexed citations
15.
Molla, Akhteruzzaman, Sudthida Vasavanonda, Gondi Kumar, et al.. (1998). Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus. Virology. 250(2). 255–262. 154 indexed citations
16.
Kumar, Gondi, et al.. (1997). Identification of cytochromes P450 involved in the human liver microsomal metabolism of the thromboxane A2 inhibitor seratrodast (ABT-001).. PubMed. 25(1). 110–5. 17 indexed citations
17.
18.
Kumar, Gondi, Swapan K. Ray, Thomas Walle, et al.. (1995). Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6?-hydroxytaxol. Cancer Chemotherapy and Pharmacology. 36(2). 129–135. 36 indexed citations
19.
Hammer, R, et al.. (1993). Soft drugs—XIV. Synthesis and anticholinergic activity of soft phenylsuccinic analogs of methatropine. Bioorganic & Medicinal Chemistry. 1(3). 183–187. 7 indexed citations
20.
Kumar, Gondi, R Hammer, & Nicholas Bodor. (1993). Soft drugs—XVI. Design, evaluation and transdermal penetration of novel soft anticholinergics based on methatropine. Bioorganic & Medicinal Chemistry. 1(5). 327–332. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard P. Murray Breakdown of academic impact, for papers by David R. Jones Breakdown of academic impact, for papers by Gareth J. Veal Breakdown of academic impact, for papers by M. J. X. Hillebrand Breakdown of academic impact, for papers by Jeffrey A. Silverman Breakdown of academic impact, for papers by Kimberly K. Adkison Breakdown of academic impact, for papers by Julia Blievernicht Breakdown of academic impact, for papers by Lindsey O. Webster Breakdown of academic impact, for papers by Matthew Wright Breakdown of academic impact, for papers by Janelle M. Hoskins
Rankless by CCL
2026